NasdaqGS - Nasdaq Real Time Price USD

Assembly Biosciences, Inc. (ASMB)

11.66
-0.75
(-6.04%)
At close: May 8 at 4:00:00 PM EDT
11.66
-0.01
(-0.06%)
After hours: May 8 at 4:05:13 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
28,520
28,520
7,163
0
6,254
Operating Expense
73,940
73,940
71,809
94,114
97,304
Operating Income
-45,420
-45,420
-64,646
-94,114
-91,050
Net Non Operating Interest Income Expense
5,573
5,573
3,451
1,022
302
Other Income Expense
5
--
--
--
-41,638
Pretax Income
-39,847
-39,847
-61,195
-93,092
-132,386
Tax Provision
330
330
33
0
-2,531
Net Income Common Stockholders
-40,177
-40,177
-61,228
-93,092
-129,855
Diluted NI Available to Com Stockholders
-40,177
-40,177
-61,228
-93,092
-129,855
Basic EPS
-6.69
--
-13.38
-23.04
-36.00
Diluted EPS
-6.69
--
-13.38
-23.04
-36.00
Basic Average Shares
6,004.56
--
4,577.37
4,034.11
3,606.70
Diluted Average Shares
6,004.56
--
4,577.37
4,034.11
3,606.70
Total Operating Income as Reported
-45,420
-45,420
-64,646
-94,114
-132,688
Total Expenses
73,940
73,940
71,809
94,114
97,304
Net Income from Continuing & Discontinued Operation
-40,177
-40,177
-61,228
-93,092
-129,855
Normalized Income
-40,177
-40,177
-61,228
-93,092
-89,008.12
Interest Income
5,573
5,573
3,451
1,022
302
Net Interest Income
5,573
5,573
3,451
1,022
302
EBIT
-45,420
-45,420
-64,646
-94,114
-91,050
EBITDA
-45,291
-45,291
-64,196
-93,616
-90,584
Reconciled Depreciation
129
129
450
498
466
Net Income from Continuing Operation Net Minority Interest
-40,177
-40,177
-61,228
-93,092
-129,855
Total Unusual Items Excluding Goodwill
--
--
--
0
-41,638
Total Unusual Items
--
--
--
0
-41,638
Normalized EBITDA
-45,291
-45,291
-64,196
-93,616
-48,946
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
-791.12
12/31/2021 - 12/17/2010

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SPRO Spero Therapeutics, Inc.
0.5750
-0.52%
 
ANTX AN2 Therapeutics, Inc.
1.2200
-1.61%
 
KROS Keros Therapeutics, Inc.
14.02
+2.26%
 
HLVX HilleVax, Inc.
1.9100
+3.24%
 
RPTX Repare Therapeutics Inc.
1.3600
0.00%
 
CLRB Cellectar Biosciences, Inc.
0.2515
+2.99%
 
CTMX CytomX Therapeutics, Inc.
1.0900
+13.48%
 
TBPH Theravance Biopharma, Inc.
9.90
-0.90%
 
VTYX Ventyx Biosciences, Inc.
1.1700
-3.31%
 
IPSC Century Therapeutics, Inc.
0.5200
-0.34%